Holen Sie sich die Stockscreener-App
30.68
15.43%
4.10
Vorhandelsmarkt:
30.23
-0.45
-1.47%
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Jefferies raises Olema Pharmaceuticals stock price target to $43 on SERD validation - Investing.com UK
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 1-Year HighHere's Why - MarketBeat
Olema Oncology (OLMA) Shares Surge Over 11% - GuruFocus
Olema Pharmaceuticals stock hits 52-week high at $29.57 By Investing.com - Investing.com Canada
Roche's SERD Trial Boosts Olema Pharmaceuticals (OLMA) Stock - GuruFocus
Olema Pharmaceuticals stock hits 52-week high at $29.57 - Investing.com
Diadema Partners LP Increases Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Sets New Standards In Oncology - Kalkine Media
Olema Pharmaceuticals joins SABCS25 to advance breast cancer therapies - Traders Union
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 7.7%Here's Why - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Moves Forward with Clinical Trials - Kalkine Media
XTX Topco Ltd Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Shares Bought by Schroder Investment Management Group - MarketBeat
Affinity Asset Advisors LLC Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (OLMA) price target increased by 53.92% to 37.23 - MSN
Olema Pharmaceuticals Inc Stock Analysis and ForecastVolume Profile Analysis & Turn Data into Profits With Our Strategies - earlytimes.in
Why Olema Pharmaceuticals Inc. stock is rated strong buyChart Signals & Capital Protection Trade Alerts - Newser
Why retail investors favor Olema Pharmaceuticals Inc. stockMarket Sentiment Review & Long-Term Growth Plans - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals seeks senior medical director to advance oncology care - Traders Union
Olema Pharmaceuticals (OLMA) Stock Analysis Report | Financials & Insights - Benzinga
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN
Olema Pharmaceuticals (OLMA): Assessing Valuation Following $190 Million Equity Offering and Underwriter Changes - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Will Olema Pharmaceuticals Inc. stock pay special dividends2025 Price Targets & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Canada
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD - Investing.com
15,000 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by Titleist Asset Management LLC - MarketBeat
Olema Pharmaceuticals (OLMA) Bolsters Balance Sheet but Will Fresh Capital Accelerate Oncology Innovation? - Sahm
Olema Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Dir Rappaport Acquires 35,868 Of Olema Pharmaceuticals Inc [OLMA] - TradingView
[Form 4] Olema Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - MSN
Olema Pharmaceuticals (OLMA): Evaluating the Current Valuation After a Strong Run-Up in Recent Months - Yahoo Finance
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - MSN
LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA) - The Globe and Mail
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
The Goldman Sachs Group Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $26.00 - MarketBeat
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Research Analysts Set Expectations for OLMA Q1 Earnings - MarketBeat
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Goldman Sachs Maintains Olema Pharmaceuticals (OLMA) Buy Recommendation - MSN
Olema Pharmaceuticals Inc. (OLMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Small Cap Stocks To Keep An Eye OnNovember 18th - MarketBeat
Goldman Sachs Raises Price Target for Olema Pharmaceuticals (OLM - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 26%What's Next? - MarketBeat
Commit To Purchase Olema Pharmaceuticals At $16, Earn 40.4% Annualized Using Options - Nasdaq
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Olema Pharmaceuticals Closes $218.5 Million Public Offering of Common Stock - Quiver Quantitative
Olema Oncology (Nasdaq: OLMA) Completes $218.5M Equity Sale at $19 Per Share - Stock Titan
Olema Pharmaceuticals (NASDAQ:OLMA) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Olema Pharmaceuticals Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - MarketScreener
What technical signals suggest for Olema Pharmaceuticals Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneProfit Target & AI Based Trade Execution Alerts - newser.com
Will Olema Pharmaceuticals Inc. continue its uptrendIPO Watch & Short-Term Swing Trade Alerts - newser.com
Potential Buying Opportunity for OLMA? - StocksToTrade
Is Olema Pharmaceuticals Inc. stock attractive for passive investorsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Olema Pharmaceuticals Announces Public Stock Offering - TipRanks
Olema Pharmaceuticals Announces Follow-On Public Offering - TradingView
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):